 |
|
Diabetes Mellitus and the Risk of Cancer
Results From a Large-Scale Population-Based Cohort Study in Japan
Manami Inoue, MD, PhD;
Motoki Iwasaki, MD, PhD;
Tetsuya Otani, MD, PhD;
Shizuka Sasazuki, MD, PhD;
Mitsuhiko Noda, MD;
Shoichiro Tsugane, MD, DMSc; for the Japan Public Health Center–Based Prospective Study Group
Arch Intern Med. 2006;166:1871-1877.
Background An association between diabetes mellitus (DM) and cancer has long been speculated, but no conclusive evidence has been obtained.
Methods We prospectively examined the association between a history of DM and subsequent risk of cancer in the Japan Public Health Center–Based Prospective Study. A total of 97 771 general Japanese persons (46 548 men and 51 223 women) aged 40 to 69 years who responded to the baseline questionnaire, from January 1990 to December 1994, were followed up for cancer incidence through December 31, 2003. At baseline, 6.7% of men and 3.1% of women had a history of DM.
Results A total of 6462 cases of newly diagnosed cancer were identified. In men, a 27% increase in the risk of total cancer incidence was observed in those with a history of DM (n = 3907 [366 with DM]; hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.14-1.42). The HR was especially high for those with cancer of the liver (n = 312 [52 with DM]; HR, 2.24; 95% CI, 1.64-3.04), pancreas (n = 118 [16 with DM]; HR, 1.85; 95% CI, 1.07-3.20), and kidney (n = 99 [13 with DM]; HR, 1.92; 95% CI, 1.06-3.46). We also observed a moderately increased risk of colon cancer (n = 491 [46 with DM]; HR, 1.36; 95% CI, 1.00-1.85) and of stomach cancer with borderline significance (n = 977 [87 with DM]; HR, 1.23; 95% CI, 0.98-1.54). In women, a borderline significant increase in risk was observed for the incidence of total cancer (n = 2555 [104 with DM]; HR, 1.21; 95% CI, 0.99-1.47), while statistical significance was observed for the incidence of stomach cancer (n = 362 [20 with DM]; HR, 1.61; 95% CI, 1.02-2.54) and liver cancer (n = 120 [10 with DM]; HR, 1.94; 95% CI, 1.00-3.73) and borderline significance was observed for the incidence of ovarian cancer (n = 74 [5 with DM]; HR, 2.42; 95% CI, 0.96-6.09).
Conclusion Patients with DM drawn from the general Japanese population may be at increased risk of total cancer and of cancer in specific sites.
Author Affiliations: Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center (Drs Inoue, Iwasaki, Otani, Sasazuki, and Tsugane), and Department of Endocrinology and Metabolism and Clinical Laboratory Department, International Medical Center of Japan (Dr Noda), Tokyo, Japan.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona and Dhindsa
J. Clin. Endocrinol. Metab. 2011;96:2643-2651.
ABSTRACT
| FULL TEXT
Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan
Tseng
Gut 2011;60:774-779.
ABSTRACT
| FULL TEXT
Prospective Study of Self-Reported Diabetes and Risk of Upper Gastrointestinal Cancers
Lin et al.
Cancer Epidemiol. Biomarkers Prev. 2011;20:954-961.
ABSTRACT
| FULL TEXT
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
Lam et al.
Ann Oncol 2011;22:730-738.
ABSTRACT
| FULL TEXT
Diabetes and Cancer
Chowdhury
QJM 2010;103:905-915.
ABSTRACT
| FULL TEXT
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Stepanova et al.
Gut 2010;59:1410-1415.
ABSTRACT
| FULL TEXT
High Dietary Intake of Magnesium May Decrease Risk of Colorectal Cancer in Japanese Men
Ma et al.
J. Nutr. 2010;140:779-785.
ABSTRACT
| FULL TEXT
Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection
Lagiou et al.
Ann Oncol 2009;20:1741-1745.
ABSTRACT
| FULL TEXT
Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection
Rossi et al.
Ann Oncol 2009;20:1736-1740.
ABSTRACT
| FULL TEXT
The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health Disparities
Diaz et al.
J Am Board Fam Med 2009;22:521-527.
ABSTRACT
| FULL TEXT
The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses
Wang et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2054-2060.
ABSTRACT
| FULL TEXT
Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
Yang et al.
Diabetes 2009;58:1518-1525.
ABSTRACT
| FULL TEXT
Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Chao and Page
Am J Epidemiol 2008;168:471-480.
ABSTRACT
| FULL TEXT
Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study
Ohishi et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:846-854.
ABSTRACT
| FULL TEXT
Cardiorespiratory Fitness as a Predictor of Cancer Mortality Among Men With Pre-Diabetes and Diabetes
Thompson et al.
Diabetes Care 2008;31:764-769.
ABSTRACT
| FULL TEXT
Glycemic Status and Risk of Prostate Cancer
Darbinian et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:628-635.
ABSTRACT
| FULL TEXT
Population-based Case-Control Study of Diabetes and Breast Cancer Risk in Hispanic and Non-Hispanic White Women Living in US Southwestern States
Rollison et al.
Am J Epidemiol 2008;167:447-456.
ABSTRACT
| FULL TEXT
Symposium introduction: metabolic syndrome and the onset of cancer
Zhou et al.
Am J Clin Nutr 2007;86:817S-819S.
ABSTRACT
| FULL TEXT
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue and Michels
Am J Clin Nutr 2007;86:823S-835S.
ABSTRACT
| FULL TEXT
Peroxisome proliferator-activated receptor {gamma} agonists inhibit the proliferation and invasion of human colon cancer cells
Shen et al.
Postgrad. Med. J. 2007;83:414-419.
ABSTRACT
| FULL TEXT
|
